ImportRefusal LogoImportRefusal

Zhejiang Huahai Pharmaceutical

⚠️ Moderate Risk

FEI: 3003885745 • Linhai, Taizhou Zhejiang • CHINA

FEI

FEI Number

3003885745

📍

Location

Linhai, Taizhou Zhejiang

🇨🇳

Country

CHINA
🏢

Address

Coastal Industrial Zone, Chuannan No. 1 Branch No. 9, Donghai 5th Avenue, Linhai, Taizhou Zhejiang, China

Moderate Risk

FDA Import Risk Assessment

27.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
5
Unique Violations
1/21/2016
Latest Refusal
1/7/2003
Earliest Refusal

Score Breakdown

Violation Severity
56.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
1.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2231×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

28801×

RXCOMPOUND

the labeling fails to bear, at a minimum, the symbol "Rx only."

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
1/21/2016
62OIY20CAPTOPRIL (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
1/7/2003
62OCS20CAPTOPRIL (ANTI-HYPERTENSIVE - PART II)
118NOT LISTED
223FALSE
2880RXCOMPOUND
336INCONSPICU
Detroit District Office (DET-DO)

Frequently Asked Questions

What is Zhejiang Huahai Pharmaceutical's FDA import refusal history?

Zhejiang Huahai Pharmaceutical (FEI: 3003885745) has 2 FDA import refusal record(s) in our database, spanning from 1/7/2003 to 1/21/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Zhejiang Huahai Pharmaceutical's FEI number is 3003885745.

What types of violations has Zhejiang Huahai Pharmaceutical received?

Zhejiang Huahai Pharmaceutical has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Zhejiang Huahai Pharmaceutical come from?

All FDA import refusal data for Zhejiang Huahai Pharmaceutical is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.